Advertisement

Magnesium Sulfate Injection

[13 August 2016]

Products Affected - Description

Magnesium sulfate intravenous injection, American Regent
500 mg/mL, 2 mL vial, 25 count (NDC 00517-2602-25)
500 mg/mL, 10 mL vial, 25 count (NDC 00517-2610-25)
500 mg/mL, 50 mL vial, 25 count (NDC 00517-2650-25)

Magnesium sulfate intravenous injection, Fresenius Kabi
500 mg/mL, 10 mL vial, 25 count (NDC 63323-0064-10)
500 mg/mL, 20 mL vial, 25 count (NDC 63323-0642-20)
500 mg/mL, 50 mL vial, 25 count (NDC 63323-0642-50)
 
Magnesium sulfate intravenous injection, Hospira
500 mg/mL, 20 mL vial, 25 count (NDC 00409-2168-02)

Reason for the Shortage

  • American Regent has had magnesium sulfate unavailable since late 2012.
  • Fresenius Kabi has magnesium sulfate injection on shortage due to increased demand for the product. The company has launched 2 new NDC codes for magnesium sulfate 20 mL and 50 mL vials (these replace the older codes of the 20 mL (NDC 63323-0064-20) and 50 mL (NDC 63323-0064-50) vials).
  • Hospira has magnesium sulfate injection on shortage due to manufacturing delays.
  • X-Gen had magnesium sulfate injection on shortage due to increased demand.

Available Products

Magnesium sulfate intravenous injection, Fresenius Kabi
500 mg/mL, 2 mL vial, 25 count (NDC 63323-0064-02)
 
Magnesium sulfate intravenous injection, Hospira
500 mg/mL, 10 mL syringe, 10 count (NDC 00409-1754-10)
 
Magnesium sulfate intravenous injection, X-Gen
500 mg/mL, 10 mL vial, 25 count (NDC 39822-4025-02)

Premixed bags in 5% Dextrose
Magnesium sulfate intravenous injection, Fresenius Kabi
10 mg/mL, 100 mL premixed bag, 24 count (NDC 63323-0108-01)
 
Magnesium sulfate intravenous injection, Hospira
10 mg/mL, 100 mL premixed bag, 24 count (NDC 00409-6727-23)
 
Premixed bags in water
Magnesium sulfate intravenous injection, Fresenius Kabi
40 mg/mL, 50 mL premixed bag, 24 count (NDC 63323-0106-05)
40 mg/mL, 100 mL premixed bag, 24 count (NDC 63323-0106-01)
40 mg/mL, 500 mL premixed bag, 24 count (NDC 63323-0106-15)
40 mg/mL, 1000 mL premixed bag, 24 count (NDC 63323-0106-10)
80 mg/mL, 50 mL premixed bag, 24 count (NDC 63323-0107-05)
 
Magnesium sulfate intravenous injection, Hospira
40 mg/mL, 50 mL premixed bag, 24 count (NDC 00409-6729-24)
40 mg/mL, 100 mL premixed bag, 24 count (NDC 00409-6729-23)
40 mg/mL, 500 mL premixed bag, 24 count (NDC 00409-6729-03)
40 mg/mL, 1000 mL premixed bag, 24 count (NDC 00409-6729-09)
80 mg/mL, 50 mL premixed bag, 24 count (NDC 00409-6730-13)

Estimated Resupply Dates

  • Fresenius Kabi has magnesium sulfate 500 mg/mL 50 mL vials on back order and the company estimates a release date of mid-August 2016. Magnesium 500 mg/mL 10 mL and 20 mL vials are on back order and the company estimates a release date of late-August to early-September 2016.
  • Hospira has magnesium sulfate 500 mg/mL 20 mL vials on back order and the company estimates a release date of late-September 2016.

Related Shortages

Updated

August 13 and 1, July 26 and 12, June 23, 22 and 9, May 26, 2016; November 5, September 9, July 16, June 29, April 8, March 25, February 19 and 4, January 23, 2015; December 12, November 14, October 24, September 11, August 28 and 1, July 17, June 6, May 23, 12 and 1, April 22 and 9, February 7, January 3, 2014; December 9 and 4, November 19, October 31, August 26, July 11 and 3, June 27, May 24, April 17, March 27, February 5, January 23, 15 and 8, 2013; December 26, 19 and 4, November 14 and 9, October 24, 11 and 3, September 14, August 22, June 18, May 15 and 1, April 17, March 28 and 7, February 16 and 1, January 27, 2012; December 28 and 7, November 22 and 10, October 31, 28, 18, 11, 6 and 5, September 20 and 16, August 31, July 22, June 23, May 26, April 29 and 28, March 31 and 30, 2011, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing